183 related articles for article (PubMed ID: 33248687)
1. The conserved arginine residue in all siglecs is essential for Siglec-7 binding to sialic acid.
Yoshimura A; Hatanaka R; Tanaka H; Kitajima K; Sato C
Biochem Biophys Res Commun; 2021 Jan; 534():1069-1075. PubMed ID: 33248687
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a new sialic acid binding region that regulates Siglec-7.
Yamakawa N; Yasuda Y; Yoshimura A; Goshima A; Crocker PR; Vergoten G; Nishiura Y; Takahashi T; Hanashima S; Matsumoto K; Yamaguchi Y; Tanaka H; Kitajima K; Sato C
Sci Rep; 2020 May; 10(1):8647. PubMed ID: 32457377
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
4. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
[TBL] [Abstract][Full Text] [Related]
5. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
6. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand.
Yamaguchi S; Yoshimura A; Yasuda Y; Mori A; Tanaka H; Takahashi T; Kitajima K; Sato C
Chembiochem; 2017 Jul; 18(13):1194-1203. PubMed ID: 28374980
[TBL] [Abstract][Full Text] [Related]
7. Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition.
Khatua B; Ghoshal A; Bhattacharya K; Mandal C; Saha B; Crocker PR; Mandal C
FEBS Lett; 2010 Feb; 584(3):555-61. PubMed ID: 19945458
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
9. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
Carlin AF; Lewis AL; Varki A; Nizet V
J Bacteriol; 2007 Feb; 189(4):1231-7. PubMed ID: 16997964
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
11. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.
Angata T; Margulies EH; Green ED; Varki A
Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13251-6. PubMed ID: 15331780
[TBL] [Abstract][Full Text] [Related]
12. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.
Angata T; Varki A
Glycobiology; 2000 Apr; 10(4):431-8. PubMed ID: 10764831
[TBL] [Abstract][Full Text] [Related]
13. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9.
Yamaji T; Teranishi T; Alphey MS; Crocker PR; Hashimoto Y
J Biol Chem; 2002 Feb; 277(8):6324-32. PubMed ID: 11741958
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
16. Siglecs--the major subfamily of I-type lectins.
Varki A; Angata T
Glycobiology; 2006 Jan; 16(1):1R-27R. PubMed ID: 16014749
[TBL] [Abstract][Full Text] [Related]
17. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
18. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
20. A second uniquely human mutation affecting sialic acid biology.
Angata T; Varki NM; Varki A
J Biol Chem; 2001 Oct; 276(43):40282-7. PubMed ID: 11546777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
